← All trials
NCT00038727
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2002
- Primary completion
- Oct 1, 2013
- Completion date
- Jan 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 2776
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Lead sponsor
- American Diabetes AssociationCollaborator
- Indian Health ServiceCollaborator
- University of ChicagoOverall official - principal investigator
- University of MiamiOverall official - principal investigator
- University of Colorado, DenverOverall official - principal investigator
- Joslin Diabetes CenterOverall official - principal investigator
- University of WashingtonOverall official - principal investigator
- Northwestern UniversityOverall official - principal investigator
- University of VermontOverall official - principal investigator
- University of Texas, San AntonioOverall official - principal investigator
- University of California, San DiegoOverall official - principal investigator
- St. Luke's-Roosevelt Hospital CenterOverall official - principal investigator
- Indiana UniversityOverall official - principal investigator
- University of California, Los AngelesOverall official - principal investigator
- University of PittsburghOverall official - principal investigator
- University of HawaiiOverall official - principal investigator
- Harvard UniversityOverall official - principal investigator
- University of New MexicoOverall official - principal investigator
- Johns Hopkins UniversityOverall official - principal investigator
- Yeshiva UniversityOverall official - principal investigator
- Thomas Jefferson UniversityOverall official - principal investigator
- University of TennesseeOverall official - principal investigator
- George Washington UniversityOverall official - principal investigator
- Harvard UniversityStudy chair
- National Institute on Aging (NIA)Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)Collaborator
- National Cancer Institute (NCI)Collaborator
- National Eye Institute (NEI)Collaborator
- National Center for Research Resources (NCRR)Collaborator
- Washington University in St. LouisOverall official - principal investigator
- National Institutes of Health (NIH)Overall official - principal investigator
- National Institutes of Health (NIH)Official
- National Institutes of Health (NIH)Collaborator
- Department of Veteran AffairsCollaborator
- Georgetown UniversityOverall official - principal investigator
- Centers for Disease Control and Prevention (CDC)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.